Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

In November 2018, we diagnosed a cluster of falciparum malaria cases in three Chilean travelers returning from Nigeria. Two patients were treated with sequential intravenous artesunate plus oral atovaquone/proguanil (AP) and one with oral AP. The third patient, a 23-year-old man, presented with fever on day 29 after oral AP treatment and was diagnosed with recrudescent falciparum malaria. The patient was then treated with oral mefloquine, followed by clinical recovery and resolution of parasitemia. Analysis of day 0 and follow-up blood samples, collected on days 9, 29, 34, 64, and 83, revealed that parasitemia had initially decreased but then increased on day 29. Sequencing confirmed Tyr268Cys mutation in the cytochrome b gene, associated with atovaquone resistance, in isolates collected on days 29 and 34 and P. falciparum dihydrofolate reductase mutation Asn51Ile, associated with proguanil resistance in all successfully sequenced samples. Molecular characterization of imported malaria contributes to clinical management in non-endemic countries, helps ascertain the appropriateness of antimalarial treatment policies, and contributes to the reporting of drug resistance patterns from endemic regions.

Citation

Stella M Chenet, Alan Oyarce, Jorge Fernandez, Rafael Tapia-Limonchi, Thomas Weitzel, Juan R Tejedo, Venkatachalam Udhayakumar, María Isabel Jercic, Naomi W Lucchi. Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile. The American journal of tropical medicine and hygiene. 2021 Mar 29;104(5):1811-1813

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 33782210

View Full Text